These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 32210437)
1. Inactivated rabies vaccines: Standardization of an in vitro assay for residual viable virus detection. Moreira BLC; Gimenez APL; Inagaki JMF; Raboni SM PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008142. PubMed ID: 32210437 [TBL] [Abstract][Full Text] [Related]
2. Development and validation of a real-time RT-PCR assay for the quantification of rabies virus as quality control of inactivated rabies vaccines. Lourenç Correia Moreira B; Aparecida Pereira L; Lappas Gimenez AP; Minor Fernandes Inagaki J; Raboni SM J Virol Methods; 2019 Aug; 270():46-51. PubMed ID: 31047970 [TBL] [Abstract][Full Text] [Related]
3. A versatile in vitro ELISA test for quantification and quality testing of infectious, inactivated and formulated rabies virus used in veterinary monovalent or combination vaccine. Sigoillot-Claude C; Battaglio M; Fiorucci M; Gillet D; Vimort AS; Giraud Y; Laurent S; Vaganay A; Poulet H Vaccine; 2015 Jul; 33(32):3843-9. PubMed ID: 26144898 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of a non-invasive, inhalational challenge method for rabies vaccine potency assay. Lewis CE; Reising MM; Fry AM; Conrad SK; Siev D; Gatewood DM; Hermann JR J Virol Methods; 2013 Jun; 190(1-2):49-52. PubMed ID: 23557669 [TBL] [Abstract][Full Text] [Related]
5. Sensitive procedure for detecting residual viable virus in inactivated rabies vaccine. Mitchell JR; Everest RE; Anderson GR Appl Microbiol; 1971 Oct; 22(4):600-3. PubMed ID: 4943273 [TBL] [Abstract][Full Text] [Related]
6. A multi-dose serological assay suitable to quantify the potency of inactivated rabies vaccines for veterinary use. Krämer B; Kamphuis E; Hanschmann KM; Milne C; Daas A; Duchow K Biologicals; 2013 Nov; 41(6):400-6. PubMed ID: 24144483 [TBL] [Abstract][Full Text] [Related]
7. A semi-quantitative serological method to assess the potency of inactivated rabies vaccine for veterinary use. Liu Y; Zhang S; Zhang F; Hu R Virol Sin; 2012 Aug; 27(4):259-64. PubMed ID: 22899435 [TBL] [Abstract][Full Text] [Related]
8. Development of an assay for detecting the residual viable virus in inactivated rabies vaccine by enzyme-linked immunosorbent assay. Kawahara M; Takayama-Ito M; Kato H; Kitaura S; Satoh M; Saijo M Biologicals; 2021 Apr; 70():59-63. PubMed ID: 33518433 [TBL] [Abstract][Full Text] [Related]
9. Standardization of an enzyme immunoassay for the in vitro potency assay of inactivated tissue culture rabies vaccines: determination of the rabies virus glycoprotein with polyclonal antisera. Thraenhart O; Ramakrishnan K J Biol Stand; 1989 Oct; 17(4):291-309. PubMed ID: 2613705 [TBL] [Abstract][Full Text] [Related]
10. A sensitive in vitro assay for the detection of residual viable rabies virus in inactivated rabies vaccines. Takayama-Ito M; Nakamichi K; Kinoshita H; Kakiuchi S; Kurane I; Saijo M; Lim CK Biologicals; 2014 Jan; 42(1):42-7. PubMed ID: 24321529 [TBL] [Abstract][Full Text] [Related]
11. New approach to the production of concentrated and purified inactivated polio and rabies tissue culture vaccines. van Wezel AL; van Steenis G; Hannik CA; Cohen H Dev Biol Stand; 1978; 41():159-68. PubMed ID: 223908 [TBL] [Abstract][Full Text] [Related]
12. Standardization of methods used for testing the safety of tissue culture rabies vaccines. Romanova LN; Polyushkina GS Dev Biol Stand; 1978; 40():209-13. PubMed ID: 680394 [TBL] [Abstract][Full Text] [Related]
13. Zonal-centrifuged human diploid cell rabies vaccine. Majer M; Hilfenhaus J; Mauler R; Hennessen W Dev Biol Stand; 1976 Dec 13-15; 37():267-71. PubMed ID: 801472 [TBL] [Abstract][Full Text] [Related]
14. Immunogenicity, safety and lot consistency in adults of a chromatographically purified Vero-cell rabies vaccine: a randomized, double-blind trial with human diploid cell rabies vaccine. Jones RL; Froeschle JE; Atmar RL; Matthews JS; Sanders R; Pardalos J; Moeller L; Chin JE; Famula M; Briggs DJ; Lang J Vaccine; 2001 Sep; 19(32):4635-43. PubMed ID: 11535311 [TBL] [Abstract][Full Text] [Related]
15. Development and evaluation of alternative testing methods for the in vivo NIH potency test used for the quality control of inactivated rabies vaccines. Rooijakkers E; Groen J; Uittenbogarrd J; van Herwijnen J; Osterhaus A Dev Biol Stand; 1996; 86():137-45. PubMed ID: 8785943 [TBL] [Abstract][Full Text] [Related]
16. Purification of rabies virus produced in Vero cells grown in serum free medium. Trabelsi K; Ben Zakour M; Kallel H Vaccine; 2019 Nov; 37(47):7052-7060. PubMed ID: 31300287 [TBL] [Abstract][Full Text] [Related]
17. Inactivated rabies vaccine control and release: use of an ELISA method. Fournier-Caruana J; Poirier B; Haond G; Jallet C; Fuchs F; Tordo N; Perrin P Biologicals; 2003 Mar; 31(1):9-16. PubMed ID: 12623055 [TBL] [Abstract][Full Text] [Related]
18. [Economical production of rabies vaccine on cell cultures]. Lalosević D; Lazarević-Ivanc L; Stankov S Med Pregl; 1997; 50(11-12):565-8. PubMed ID: 9471524 [TBL] [Abstract][Full Text] [Related]
19. A single center, open label study of intradermal administration of an inactivated purified chick embryo cell culture rabies virus vaccine in adults. Recuenco S; Warnock E; Osinubi MOV; Rupprecht CE Vaccine; 2017 Aug; 35(34):4315-4320. PubMed ID: 28688782 [TBL] [Abstract][Full Text] [Related]
20. [Comparison of PVRV and HDCV rabies vaccines as to immunity, reliability and protective value]. Hacibektaşoğlu A; Inal A; Eyigün C; Barut A; Türkay FA Mikrobiyol Bul; 1992 Jan; 26(1):26-36. PubMed ID: 1574019 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]